Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals reported a 167% YoY surge in consolidated net profit to ₹110.998 million for FY26, with revenue up 3.3% to ₹1.506 billion. The board approved audited financial results for Q4 and